fbpx

Författare: johan@emergers.se

GRANGEX: Steep acceleration towards two permitted CO2-free iron ore projects

Analys, Research

GRÄNGESBERG EXPLORATION 2023 has proven a pivotal year for GRANGEX. Soon after the environmental court’s approval to restart...

Read More

KEBNI: Soft Q2 ahead of ramp-up in H2’23-2026

Analys, Research

Sales in Q2’23 of SEK 7.4m were softer than we expected. While we are optimistic about a significant increase in sales in H2’23...

Read More

NANEXA: Progress with NEX-20 and NEX-22 Amid Rising GLP-1 Interest

Analys, Research

Nanexa’s Q2’23 advancements with NEX-20 and NEX-22 underscore the company’s forward momentum. NEX-20 is set to provide a more...

Read More

KEBNI: Financing and second volume order clear path for sales surge in 2023-2026

Analys, Research

Late Wednesday evening KebNi announced that it has raised SEK 29.6m from a group of professional investors, including the two largest of...

Read More

BONZUN: Merger with L2S a favorable reconfiguration for Bonzun’s shareholders

Research

Bonzun has agreed to sell all shares in its subsidiary Bonzun Evolve to CBT-based sleep therapy company Learning to Sleep (L2S, listed on...

Read More

GRANGEX: Final regulatory hurdle cleared to materialise the world’s first CO2-free iron ore mine

Analys, Research

GRÄNGESBERG EXPLORATION The Land and Environmental Court has now granted GRANGEX the permit for mining operations at Dannemora, meaning...

Read More

BONZUN: Q1 growth and deal momentum affirm the growth story emerging in Bonzun

Research

While still modest in absolute terms, the Q1 sales growth and deals year-to-date signed affirm the growth story we see emerging in Bonzun,...

Read More

QLUCORE: Delayed CE approval suggests upcoming need for additional financing

Analys, Research

With BSI as Notified Body, Qlucore now expects to obtain CE certification for its Qlucore Diagnostics ALL application in February 2025....

Read More

KEBNI: Broad support for long-term revenue target but cash an increasing concern

Analys, Research

KebNi reported an 80% revenue growth in Q1’23, to SEK 10.9m, largely due to sales of satellite antennas to IAI. Despite a variety of...

Read More

NANEXA: Solid progress in development into 2023, with funding needs on the horizon

Analys, Research

After positive pre-clinical results in rats with NEX-22 (for treatment of type 2 diabetes) in Q1, we now see results from phase I for...

Read More

For new research on growth stocks, sign up to our newsletter